ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,956Medicare Part D Prescriptions Filled, Including Refills

Rank: 291 out of 944

$500K Total Retail Price of All Prescriptions

Rank: 212 out of 944

389 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 389 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 389 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
OMEPRAZOLE 320 250 1 4
SIMVASTATIN 285 271 2 1
LEVOTHYROXINE SODIUM 258 227 3 2
LISINOPRIL 239 210 4 3
CRESTOR 225 169 5 28
FUROSEMIDE 221 212 6 6
AMLODIPINE BESYLATE 200 175 7 5
ATORVASTATIN CALCIUM 193 183 8 13
METOPROLOL TARTRATE 165 150 9 8
HYDROCHLOROTHIAZIDE 160 147 10 9
ATENOLOL 138 121 11 11
RANITIDINE HCL 134 97 12 42
TIZANIDINE HCL 128 38 13 167
HYDROCODONE-ACETAMINOPHEN 113 91 S3 14 10
CITALOPRAM HBR 110 86 15 19
GABAPENTIN 109 75 16 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 83 17 29
TAMSULOSIN HCL 99 99 18 27
METOPROLOL SUCCINATE 92 78 19 14
POTASSIUM CHLORIDE 91 91 20 15
WARFARIN SODIUM 89 89 21 7
FENTANYL 85 45 S2 22 57
METFORMIN HCL 82 69 23 12
DOXAZOSIN MESYLATE 81 80 24 60
HYDROXYZINE HCL 73 13 R 25 231
SERTRALINE HCL 70 59 26 23
LOVASTATIN 68 68 27 26
ALLOPURINOL 66 66 28 22
QUETIAPINE FUMARATE 66 66 28 69
ZETIA 64 48 30 59
PANTOPRAZOLE SODIUM 61 41 31 34
TRAZODONE HCL 61 56 31 45
MIRTAZAPINE 61 57 31 35
DIOVAN 57 57 34 38
LOSARTAN POTASSIUM 57 53 34 16
DONEPEZIL HCL 57 57 34 24
PREDNISONE 56 51 37 32
ZOLPIDEM TARTRATE 55 45 38 25
DIGOXIN 55 55 38 39
VOLTAREN 55 46 38 223
NAMENDA 53 53 41 37
SUMATRIPTAN SUCCINATE 52 32 42 271
PROPRANOLOL HCL 50 49 43 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.